CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.
Authors
Alona Muzikansky
Andrew S. Chi
+11Â more
Bruce R. Rosen
Elizabeth Robins Gerstner
Jayashree Kalpathy-Cramer
John Evans
Jorg Dietrich
Kyrre E. Emblem
Patrick Y. Wen
Tracy Batchelor
Vyshak Chandra
Xuezhu Cai
Yangming Ou
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 25/10/2020